Literature DB >> 8956719

Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactions.

H H Hamdalla, C H Hawkes, E G Spokes, J M Bamford, P J Goulding.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956719      PMCID: PMC2352928          DOI: 10.1136/bmj.313.7069.1399c

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Intravenous IgG in Guillain-Barré syndrome.

Authors:  R A Hughes
Journal:  BMJ       Date:  1996-08-17

2.  The OPCS: many (more) happy returns?

Authors:  T Delamothe
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-04
  2 in total
  1 in total

Review 1.  Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.

Authors:  Matthias Wittstock; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.